Statement on Future U.S. BrainStorm Trial

April 3, 2014

The Northeast ALS Consortium (NEALS) has had many inquiries regarding the BrainStorm Stem Cell Therapeutics Clinical Trial. BrainStorm is currently conducting a Phase IIa dose-escalating trial at the Hadassah Medical Center in Israel. NEALS is working with BrainStorm on a planned Phase II study in the U.S. and hope to begin the trial this year. We are continuing to follow the progress of the study in Israel and will keep the NEALS website current on all new trials and start dates.

UPDATE: (January 6, 2014) Protocol information and eligibility criteria for the BrainStorm trial have been posted on the US Government’s clinical trials website. Please note, however, that the study has not yet been approved by the FDA, and recruitment has not started. Please continue to check NEALS for developments about this trial.

For more information, please visit www.brainstorm-cell.com.

Powered by Blackbaud
nonprofit software